Follow us on:

Sativa Wellness Group exceptionally strong results (Interview)

Sativa Wellness Group inc. (LON:SWEL) Executive Chairman Geremy Thomas joins DirectorsTalk Interviews to discuss its first quarterly profit in Q2 2021. Geremy talks us through the results highlights and explains the companies plans for the second half.

Sativa Wellness Groups goal is to build Europe’s leading CBD Wellness brands and to meet today’s fast evolving consumer expectations. Through full vertical integration of their supply chain, they plan to become one of the premier low-cost producers and high-quality distributors of CBD wellness products in Europe.

Find more news, interviews, share price & company profile here for:Goodbody Health

Share this interview

Other Interviews

More News

Sativa Wellness expands COVID testing clinic in store to Bristol December 8, 2020
Sativa Wellness welcomes ECJ ruling on CBD November 24, 2020
Sativa Wellness Secures Significant Product Listing with the Health Store October 6, 2020
Sativa Wellness Group a true seed to consumer company (Interview) October 1, 2020
Sativa Group approved listing for Sativa Wellness Group on Canadian Securities Exchange September 10, 2020

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.